CAS 38456-39-2: 2-Butenoic acid, 2-(hydroxymethyl)-, (3aR,4R,6E,8S,10E,11aR)-2,3,3a,4,5,8,9,11a-octahydro-8-hydroxy-6,10-dimethyl-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, (2Z)-

Deacetyleupaserrin is an antileukemic sesquiterpene lactone.

Deacetyleupaserrin is a secondary metabolite, which is derived from specific fungal sources. It has gained scientific interest due to its potential as an antimicrobial compound. The mode of action of Deacetyleupaserrin involves disrupting bacterial cell walls, which inhibits their ability to proliferate and survive. This characteristic makes it a promising candidate in the development of new antibiotics, particularly against drug-resistant strains of bacteria. Research into Deacetyleupaserrin focuses on its biochemical interactions and potential therapeutic applications. It is being studied for its efficacy in treating bacterial infections where traditional antibiotics fail due to resistance. Moreover, its role in agricultural applications is also being explored, where it could help in controlling plant pathogen outbreaks. The understanding of its biosynthetic pathway is crucial for optimizing its production and enhancing its activity. Scientists are particularly interested in the structural modifications of Deacetyleupaserrin to potentially increase its potency and selectivity towards targeted bacterial strains.